{"disease":{"id":"hormone-receptor-positive-human-epidermal-growth-factor-receptor-2-negative-her2-negative-advanced-or-metastatic-breast-cancer-in-combination-with-an-aromatase-inhibitor-as-initial-endocrine-based-therapy-in-postmenopausal-women-with-estrogen-receptor-positive-er-her2-negative-breast-cancer.md","name":"hormone receptor positive human epidermal growth factor receptor 2 negative her2 negative advanced or metastatic breast cancer in combination with an aromatase inhibitor as initial endocrine based therapy in postmenopausal women with estrogen receptor positive er her2 negative breast cancer.md"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[],"total":0},"guidelines":[],"source":"Drug Landscape verified database"}